WORK Medical Technology Group Ltd (WOK)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026

Auckland, New Zealand, June 16, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

WORK Medical Technology Group Participated in 2026 CBA-China Annual Conference

Deepening Engagement with the Global Biopharmaceutical Community Auckland, New Zealand, June 05, 2026 (GLOBE...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

WORK Medical Technology Group Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy

Hangzhou, China, June 03, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK...

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

AI Healthcare and BioToken Partnership Expands WORK Medical’s (WOK) Digital Asset Ambitions

WORK Medical is pushing deeper into AI-driven healthcare and digital biological asset development through a new collaboration focused on protein...